Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GANCICLOVIR Cause Diffuse large b-cell lymphoma? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Diffuse large b-cell lymphoma have been filed in association with GANCICLOVIR (Ganciclovir). This represents 0.1% of all adverse event reports for GANCICLOVIR.

7
Reports of Diffuse large b-cell lymphoma with GANCICLOVIR
0.1%
of all GANCICLOVIR reports
3
Deaths
3
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From GANCICLOVIR?

Of the 7 reports, 3 (42.9%) resulted in death, 3 (42.9%) required hospitalization, and 3 (42.9%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GANCICLOVIR. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does GANCICLOVIR Cause?

Off label use (1,104) Drug ineffective (924) Cytomegalovirus infection (668) Drug resistance (594) Pancytopenia (403) Product use in unapproved indication (400) Neutropenia (396) Cytomegalovirus infection reactivation (301) Cytomegalovirus viraemia (294) Product use issue (279)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which GANCICLOVIR Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

GANCICLOVIR vs GANIRELIX GANCICLOVIR vs GATIFLOXACIN GANCICLOVIR vs GEFITINIB GANCICLOVIR vs GELATIN GANCICLOVIR vs GEMCITABINE

Related Pages

GANCICLOVIR Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma GANCICLOVIR Demographics